Tomorrows, a global health technology company that connects patients and physicians with pre-approval treatments, today published a new data report, entitled Searching for solutions: How physicians ...

In the Phase III CARES trials, anselamimab did not meet the primary endpoint for advanced-stage AL amyloidosis, but a ...

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug.

Tony Newberne is a high-risk multiple myeloma survivor. He is also a CPT, dietary manager, and patient advocate for several ...

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile ...

A new study by a Tulane University researcher casts doubt on a widely used shortcut in rectal cancer drug trials, raising concerns that some treatments may be fast-tracked for approval without ...

A multisite research team has issued ethical and policy recommendations for first-in-human clinical trials involving the transplantation of pig kidneys into humans. The first trial has been approved ...

Scientists have used AI to re-analyse a clinical trial for an Alzheimer's medicine, and identified a group of patients who responded to treatment. The ...

New clinical trials are advancing in hard-to-treat cancers, offering targeted and less toxic options for patients with ...

UK & Ireland, experts provided insights on market trends within the clinical trial industry and advice on engagement strategies.

Ahmedabad: Quoting a report of the Comptroller and Auditor General (CAG) of India, the Congress party alleged on Thursday ...

Bringing trials into the digital age — this alliance promises faster, smarter breakthroughs for patients down under.